There are other objective and subjective assessments that were not done on the patient Ms. BD. The patient’s nutrition was not checked. The patient’s iodine rate was supposed to be checked, symptoms of poor nutrition were supposed to be looked into. This test is critical because, poor maternal nutrition has negative feedbacks on the pregnancy, such as giving, birth to a small baby or one who has a small stature. Her body temperature was also not measured. The temperature of the patient was supposed to be measured to see if it is on the average range, so that in case, of any abnormality, the patient is treated accordingly. The patient was supposed to be checked if she has diabetes. Her previous files should be looked into and the health of the babies she had given birth to previously to know what kind of treatment to put her on.
No, Prinzide is harmful to a pregnant woman and the unborn baby. It might cause several complications to the pregnancy and the patient (Redman, 1977). The medication causes fetal abnormality in that the unborn child might even die. The patient, on the other hand, might experience dizziness and fatigues.
Delegate your assignment to our experts and they will do the rest.
The evaluation of the laboratory value test above is quite critical because they will give the route of how the treatment process will be conducted. For instance, the assessment of Potassium will be used to evaluate the following; the potassium evaluates the fluid and electrolyte instabilities in the hypersensitive patient in our case Ms. BD and evaluates the impact of therapeutic of diuretics. It is also essential to asses to see how the organs are functioning due to the effect of hypertension to know the right pharmacological drugs to put in use.
Yes, the changes of the medications will be changed compared to the previous one used which was Prinzide. The medication to be prescribed will be Methyldopa. The prescribed dosage medical safety for this medicine is 3g a day, which is the maximum dosage recommended. The normal dose ranges between 500 mg to 2 g daily. The half-life of the treatment is 105 minutes. It has a short period of action, and hypertension comes back after 48 hours. The blood pressure comes back to the pretreatment level within 24-48 hours. The metabolization is extensive. The 70% of the drug consumed is excreted in urine form as methyldopa. The medication is eliminated from the body quickly; therefore, the treatment does not stay in the body for long. The contraindications are for patients with; hypersensitivity to any component in the medication and with active hepatic diseases. The black box of this medication is it is important to know that a positive Coombs test and disorders of the liver may occur with Methyldopa therapy.
The health maintenance and prevention education suitable of the client will be that on nutrition in that the client should ensure she has good nutrition (Thomas, 2008). She should also be educated on the importance of enough rest, proper hygiene, immunization, breastfeeding ways, and also family planning.
The patient will be referred to a cardiologist or nephrologists who specialize in patients with a high blood pressure of all kinds.
References
Redman, C. B. (1977). Treatment of hypertention in pregnancy with methyldopa : blood pressure control and side effects. BJOG:An International Journal of Obsterics & Gynaecology , 419-426.
Thomas, N. J. (2008). Oral and dental health care practices in pregnant women in Australia :a postnatal survey. In BMC pregancy and birth control 8(1) (p. 13).
